Kaufman Bros. Starts NVIDIA (NVDA) at Buy; Major Beneficiary of the Convergence of Mobility and Computing
Tweet
Share
E-mail
Get Alerts NVDA Hot Sheet
Price: $225.01 -0.07%
Rating Summary:
58 Buy, 10 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
58 Buy, 10 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Kaufman Bros. initiates coverage on NVIDIA (NASDAQ: NVDA) with a Buy. PT $18.00.
Kaufman analyst says, "We view NVDA as a major beneficiary of the convergence of mobility and computing, and an increasing focus on power efficient processing, which should help the company leverage its core competencies in Visual and Parallel Computing...We are introducing CY2011 revenue and EPS (ex. items, including stock-based comp) estimates of $4.14B/$1.04 vs. the Street at $4.12B/$0.99. We are also forecasting CY2012 revenue and EPS (ex. items, including SBC) of $4.54B/$1.20 vs. the Street at $4.45B/$1.14. Our non-GAAP EPS estimate for CY2012 (excluding SBC) is $1.39."
For more ratings news on NVIDIA click here and for the rating history of NVIDIA click here.
Shares of NVIDIA closed at $13.31 yesterday.
Kaufman analyst says, "We view NVDA as a major beneficiary of the convergence of mobility and computing, and an increasing focus on power efficient processing, which should help the company leverage its core competencies in Visual and Parallel Computing...We are introducing CY2011 revenue and EPS (ex. items, including stock-based comp) estimates of $4.14B/$1.04 vs. the Street at $4.12B/$0.99. We are also forecasting CY2012 revenue and EPS (ex. items, including SBC) of $4.54B/$1.20 vs. the Street at $4.45B/$1.14. Our non-GAAP EPS estimate for CY2012 (excluding SBC) is $1.39."
For more ratings news on NVIDIA click here and for the rating history of NVIDIA click here.
Shares of NVIDIA closed at $13.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Industrial Robot Installations Hit Record Highs Amid Labor Shortage Crisis
- Jefferies Assumes Honeywell International (HON) at Hold
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Kaufman Bros.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
